Hide
Hello. Thank you for reaching out with your question regarding CMS135v10, Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD).
Population 2 is intended to measure patients at each hospital discharge. If a patient has multiple hospital discharges where a diagnosis of Moderate or Severe LVSD exists, each discharge should be considered in the denominator and numerator of the measure. Please refer to the Rate Aggregation section of the measure header for more information on how this measure is calculated.
This measure is intended to have one reporting rate, which aggregates the following populations into a single performance rate for reporting purposes:
- Population 1: Patients who were prescribed ACE inhibitor or ARB or ARNI therapy within a 12-month period when seen in the outpatient setting
- Population 2: Patients who were prescribed ACE inhibitor or ARB or ARNI therapy at each hospital discharge
For the purposes of this measure, a single performance rate can be calculated as follows:
Performance Rate = (Numerator 1 + Numerator 2)/ [(Denominator 1 - Denominator Exceptions 1) + (Denominator 2 - Denominator Exceptions 2)]
Starting with CMS135v11, Population 2 has been removed from this measure. Please let us know if you have additional questions.
Show
Hello. Thank you for reaching out with your question regarding CMS135v10, Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD).
Population 2 is intended to measure patients at each hospital discharge. If a patient has multiple hospital discharges where a diagnosis of Moderate or Severe LVSD exists, each discharge should be considered in the denominator and numerator of the measure. Please refer to the Rate Aggregation section of the measure header for more information on how this measure is calculated.
This measure is intended to have one reporting rate, which aggregates the following populations into a single performance rate for reporting purposes:
- Population 1: Patients who were prescribed ACE inhibitor or ARB or ARNI therapy within a 12-month period when seen in the outpatient setting
- Population 2: Patients who were prescribed ACE inhibitor or ARB or ARNI therapy at each hospital discharge
For the purposes of this measure, a single performance rate can be calculated as follows:
Performance Rate = (Numerator 1 + Numerator 2)/ [(Denominator 1 - Denominator Exceptions 1) + (Denominator 2 - Denominator Exceptions 2)]
Starting with CMS135v11, Population 2 has been removed from this measure. Please let us know if you have additional questions.